Cahill Represents Initial Purchasers in $1.6 Billion Notes Offering for Bausch Health Companies Inc.
Date: 06/08/21
Cahill represented the initial purchasers in connection with a Rule 144A offering of $1,600,000,000 aggregate principal amount of 4.875% senior secured notes due 2028 by Bausch Health Companies Inc., a multinational specialty pharmaceutical company. Proceeds from the offering were used to fund the Company’s concurrent tender offer for an outstanding series of notes and to pay related fees, premiums and expenses.